
Genomic Analysis Uncovers Mechanisms Behind Promising New Treatment Combo for Deadly Asian-Prevalent Lymphoma
A groundbreaking phase 2 clinical trial has revealed promising results for a novel combination therapy targeting extranodal natural killer/T-cell lymphoma (ENKTL), an aggressive and notoriously difficult-to-treat blood cancer prevalent in Asian …